Neurosoft Bioelectronics develops minimally invasive brain-computer interface technology designed to improve neural data collection and support next-generation neurotechnology applications.
Neurosoft Bioelectronics, a neurotechnology company developing scalable and minimally
invasive brain-computer interfaces (BCIs), has raised $7.5 million in an
oversubscribed seed funding round led by Skybound Venture Capital, with
participation from Protocol Labs, IAG Capital Partners and Connecticut
Innovations, among others. The latest financing brings the company’s total
BCI Can Reach Millions. Neurotech Decided It Shouldn't
China moves AI brain implants from trials towards real-world use
L'interfaccia cervello-computer grande come un mirtillo che cura la depressione: al via negli Usa alla sperimentazione
LifeSci Capital Remains a Buy on Ibio (IBIO)
The limiting factor in scaling BCI has never been compute or ambition. It's been signal resolution.
The Biological Computing Co. (TBC) has raised $25 million in seed funding, Fortune has learned.
Chinese start-up firms are supercharging their efforts to develop algorithms for brain–computer interfaces that help people to…
La società che sviluppa chip per il cervello umano continua il foundraising mentre parte in tre Paesi la sperimentazione
A new policy document boosts related stocks such as Nanjing Panda Electronics and MicroPort NeuroScientific.
Brain conditions are a major challenge in today's society. Companies around the world are developing technologies to tackle this…
